Back
Fidelity Disruptive Finance ETF Vs. Amphastar Pharmaceuticals, Inc. Sector Stock Comparison
Buy
74
FDFF
Fidelity Disruptive Finance ETF
Last Price:
$35.70
Seasonality Move:
4.29%
Sell
35
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$25.26
Seasonality Move:
0.37%
Buy
74
Fidelity Disruptive Finance ETF (FDFF)
is a Buy
Is Fidelity Disruptive Finance ETF a Buy, Sell or Hold?
-
The current Fidelity Disruptive Finance ETF [FDFF] share price is $35.69. The Score for FDFF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
FDFF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.27. The Score for AMPH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDFF Stock Price Chart
What is Fidelity Disruptive Finance ETF's stock price today?
-
The Fidelity Disruptive Finance ETF share price today is $35.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDFF is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing selling pressure, which indicates risk of future bearish movement.
FDFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 59.49 | Buy |
| Chaikin Money Flow: | -1515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.71 - 35.35) | Buy |
| Bollinger Bands (100): | (34.84 - 37.72) | Sell |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 42.93 | Sell |
| Chaikin Money Flow: | -290015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.46 - 27.32) | Sell |
| Bollinger Bands (100): | (23.69 - 28.87) | Sell |
FDFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Buy |
| 20-day SMA: | 34.41 | Buy |
| 50-day SMA: | 35.07 | Buy |
| 200-day SMA: | 36.22 | Sell |
| 8-day EMA: | 35.27 | Buy |
| 20-day EMA: | 34.89 | Buy |
| 50-day EMA: | 35.19 | Buy |
| 200-day EMA: | 35.91 | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.26 | Sell |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.51 | Sell |
| 200-day SMA: | 25.69 | Sell |
| 8-day EMA: | 26.03 | Sell |
| 20-day EMA: | 26.21 | Sell |
| 50-day EMA: | 26.07 | Sell |
| 200-day EMA: | 27.97 | Sell |
Fidelity Disruptive Finance ETF Earnings Growth & FDFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.
Fidelity Disruptive Finance ETF Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||